The Dopamine Recession

A shocking financial report reveals how shrinking waistlines are creating a half-billion-dollar windfall for U.S. airlines.

[Speaker 1]: There is a famous legend in business school circles about American Airlines in the 1980s. The story goes that a clever executive realized that if they removed just one olive from every salad served in first class, nobody would notice, but the airline would save forty thousand dollars a year. [Speaker 2]: It’s the ultimate example of corporate penny-pinching. You tweak the product just enough to save money without the customer realizing it. [Speaker 1]: Exactly. But we are seeing a headline this week that flips that logic completely on its head. The airlines are about to save a fortune again. But this time, they aren’t taking the olive out of the salad. [Speaker 2]: No. This time, the passengers are taking the weight out of themselves. [Speaker 1]: It’s Wednesday, January 21, 2026, and you’re listening to The Angle. [Speaker 2]: So, we need to talk about the report that dropped last week from Jefferies Financial Group. It’s been circulating on Wall Street, but it made the front page of the LA Times because the number is just staggering. Jefferies is projecting that U.S. airlines-United, Delta, American-are going to save five hundred and eighty million dollars in fuel costs this year. [Speaker 1]: More than half a billion dollars. [Speaker 2]: Right. And they aren’t doing it by buying more efficient engines or flying better routes. That savings is coming purely from the fact that their passengers are getting lighter. [Speaker 1]: Which sounds like a joke, or at least a massive exaggeration. But when you look at the adoption curve of GLP-1 drugs-Ozempic, Wegovy, and now the oral versions-we are sitting at about twelve percent of the adult population on these medications. [Speaker 2]: And that twelve percent is statistically significant when you’re talking about heavy machinery. [Speaker 1]: That’s the angle we want to explore today. We usually talk about these drugs as a healthcare story or a vanity story. But we’ve crossed a threshold. We are witnessing a mass biological shift that is so large, it’s acting like an infrastructure upgrade for the entire economy. [Speaker 2]: It’s rippling out in ways nobody predicted. It’s changing how much fuel a jet burns, it’s breaking the algorithms that run shopping malls, and it’s even threatening the business models of casinos and bars. [Speaker 1]: We’re calling it the Dopamine Recession. And it starts with that half-billion-dollar windfall for the airlines. [Speaker 2]: So, to understand the airline math, you have to look at the mechanism of flight planning. Every single flight is a battle against gravity. A Boeing 737 Max 8 has a very specific "zero fuel weight." [Speaker 1]: Which is exactly what it sounds like-the weight of the metal, the seats, the crew, and the passengers, before you add a drop of kerosene. [Speaker 2]: Right. And for decades, airlines used a standard average weight for passengers. But as obesity rates climbed in the 90s and 2000s, they had to adjust those averages up. That meant they had to load more fuel just to carry the people. [Speaker 1]: Because fuel is heavy. If you’re heavier, you need more fuel to lift you, which adds more weight, which burns more fuel. It’s a vicious cycle. [Speaker 2]: Exactly. But now the cycle is running in reverse. The Jefferies analysis assumes the average passenger on these drugs loses about ten percent of their body weight. If you apply that across twelve percent of the flying public, you’re removing roughly 1,790 pounds of payload from every single flight. [Speaker 1]: That’s the equivalent of kicking…